Myriam I Baes

Title: Myriam I Baes: Innovator in CAR Receptor Technologies

Introduction

Myriam I Baes is a prominent inventor based in Belmont, MA (US), known for her significant contributions to the field of CAR receptor technologies. With a total of four patents to her name, she has made remarkable advancements in the identification and therapeutic applications of CAR receptors.

Latest Patents

Myriam's latest patents include groundbreaking work on car receptors and related molecules and methods. One of her notable patents discloses purified DNA encoding CAR receptors and the recombinant proteins expressed from such DNA. These recombinant receptor polypeptides are utilized to identify CAR ligands and CAR receptor binding sites, which are essential for producing therapeutics. Additionally, she has developed antibodies specific for CAR receptor polypeptides. Another significant patent focuses on the Constitutive Activator of Retinoid acid response (CAR) receptor polypeptides. This patent also details purified DNA encoding these receptors and their recombinant proteins, which are members of the nuclear hormone receptor superfamily. These innovations further aid in identifying CAR ligands and receptor binding sites, contributing to therapeutic advancements.

Career Highlights

Throughout her career, Myriam has worked with esteemed organizations, including The General Hospital Corporation. Her work has been pivotal in advancing the understanding and application of CAR receptor technologies.

Collaborations

Myriam has collaborated with notable professionals in her field, including David D Moore and Hueng-Sik Choi. These collaborations have enriched her research and contributed to her innovative patents.

Conclusion

Myriam I Baes stands out as a leading inventor in CAR receptor technologies, with her patents paving the way for future therapeutic developments. Her work continues to influence the field and inspire new innovations.